An Upstream Strategy for Treating Severe Asthma

An Upstream Strategy for Treating Severe Asthma

Thymic stromal lymphopoietin (TSLP) has been identified as starting the cascades of cytokines that result in the inflammation that underlies many cases of severe asthma. A review paper discusses how Tezspire inhibits TSLP and the evidence for its safety and efficacy in numerous clinical trials. Severe asthma is asthma that can’t be controlled with inhaled …

An Upstream Strategy for Treating Severe Asthma Read More »